FDA Inspection 1225980 — Mayo Clinic Rochester, Division Of Transfusion Medicine

Mayo Clinic Rochester, Division Of Transfusion Medicine — FEI 2172560

The FDA completed an inspection of Mayo Clinic Rochester, Division Of Transfusion Medicine on Nov 15, 2023 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 15, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rochester, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.